Clinical Read2026-09-18

Efzimfotase alfa (ALXN1850) - (CHESTNUT)

Name: Efzimfotase alfa (ALXN1850) - (CHESTNUT)
Start: 2026-09-18

AstraZeneca PLCAZN

Indication: Paediatric patients (2 to <12 years of age) with hypophosphatasia (HPP)
Stage: phase3
Event: Phase 3
Source: View catalyst source ↗